{
  "1I4.F": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "HeraMED Limited",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "HERAMEDLTD",
    "state": "NSW",
    "summary": "HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor principally for use by an expectant mother to monitor their fetus' heartbeat. It is also involved in developing EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is based in Sydney, Australia.",
    "website": "http://www.hera-med.com",
    "zipcode": "2000"
  },
  "39I.F": {
    "city": "Pinkenba",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "ImpediMed Limited",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "IMPEDIMED LTD",
    "state": "QLD",
    "summary": "ImpediMed Limited, a medical software technology company, together with its subsidiaries, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive bioimpedance spectroscopy device for the detection of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.",
    "website": "http://www.impedimed.com",
    "zipcode": "4008"
  },
  "ALT.AX": {
    "city": "Brisbane",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Analytica Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ANALYTICA FPO",
    "state": "QLD",
    "summary": "Analytica Limited designs, develops, and supplies medical devices in Australia, the United Kingdom, and the United States. The company's lead product is PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.",
    "website": "http://www.analyticamedical.com",
    "zipcode": "4000"
  },
  "AMEUF": {
    "city": "Toowong",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Anteris Technologies Ltd",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ANTERIS TECHNOLOGIES LTD",
    "state": "QLD",
    "summary": "Anteris Technologies Ltd operates as a structural heart company. The company offers ADAPT technology, which re-engineers xenograft tissue into a pure collagen scaffold; and develops DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. It also researches and develops regenerative medicine and immunotherapies. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.",
    "website": "http://www.anteristech.com",
    "zipcode": "4066"
  },
  "AMT.AX": {
    "city": "Lane Cove West",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Allegra Orthopaedics Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ALLEGRA FPO",
    "state": "NSW",
    "summary": "Allegra Orthopaedics Limited designs, sells, and distributes orthopaedic implant products in Australia and New Zealand. The company operates through Orthopaedics Division and Innovation Division segments. It offers adult and adolescent clavicle fixation systems; shoulder implants; ulna heads, compression screws, distal radius systems, and hand fracture systems; reconstruction prosthesis, modular tumor and revision systems, partial pelvis replacement, cementless stems, cups, and ceramic prosthesis heads for hips; and knee replacement systems and knee distal first instruments. The company also provides foot and ankle products, such as total ankle replacement systems, toe products, A-curve handles, screws, staples, and foot systems; surgical screws, sawblades, and kirschner wires and pins; NanoFx, a solution for microfracture; and face shields and mask strap holders. The company was formerly known as Advanced Surgical Design & Manufacture Limited and changed its name to Allegra Orthopaedics Limited in November 2014. Allegra Orthopaedics Limited was founded in 1994 and is based in Lane Cove West, Australia.",
    "website": "http://www.allegraorthopaedics.com",
    "zipcode": "2066"
  },
  "AT1.AX": {
    "city": "Leichhardt",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Atomo Diagnostics Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "ATOMO DIAG FPO",
    "state": "NSW",
    "summary": "Atomo Diagnostics Limited researches, designs, develops, manufactures, and sells medical devices for blood-based rapid testing for professional use and self-testing. The company offers AtomoRapid RDT platforms to suit various blood-based lateral flow test assays and are appropriate for a range of applications, including screening for chronic conditions and detection of infectious diseases. Its rapid test devices are used by healthcare professionals and by consumers to screen for a range of diseases and medical conditions, including HIV infection. The company has operations in Europe, Asia, Africa, and Central and South America. Atomo Diagnostics Limited was founded in 2010 and is headquartered in Leichhardt, Australia.",
    "website": "http://atomodiagnostics.com",
    "zipcode": "2040"
  },
  "AVR.AX": {
    "city": "Toowong",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Anteris Technologies Ltd",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ANTERIS FPO",
    "state": "QLD",
    "summary": "Anteris Technologies Ltd operates as a structural heart company. The company offers ADAPT technology, which re-engineers xenograft tissue into a pure collagen scaffold; and develops DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. It also researches and develops regenerative medicine and immunotherapies. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.",
    "website": "http://www.anteristech.com",
    "zipcode": "4066"
  },
  "CBL.AX": {
    "city": "Surrey Hills",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Control Bionics Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "CTRLBIONIC FPO",
    "state": "VIC",
    "summary": "Control Bionics Limited designs, manufactures, and sells wireless wearable electromyography based augmentative and alternative communication technologies that allow users to operate and communicate through a computer using their thoughts and neuroelectric signals. It offers Eye Control Duo, an integrated eye tracking device for those living with paralysis and loss of speech; NeuroNode Trilogy, a solution for those living with paralysis and loss of speech; and Control Bionics Complete Communication System, an out of the box solution for those living with paralysis and loss of speech. The company also provides support and warranty services. The company's products are used by people suffering from diseases, such as motor neuron diseases, amyotrophic lateral sclerosis, cerebral palsy, multiple sclerosis, and spinal cord injuries. It operates in Australia, the United States, Japan, and internationally. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Surrey Hills, Australia.",
    "website": "http://www.controlbionics.com",
    "zipcode": "3127"
  },
  "CDX.AX": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "CardieX Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CARDIEXLTD FPO",
    "state": "NSW",
    "summary": "CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company develops, markets, and distributes medical technologies that measure patient risk for hypertension, cardiovascular disease (CVD), and other related vascular disorders. It also provides TeleHealth Services, which provides digital, e-commerce, and mobile tools for patients to connect online with health coaches. The company offers its devices and services to hospitals, clinics, research institutions and pharmaceutical companies. CardieX Limited has a strategic collaboration with Blumio Inc. to develop wearable sensor; and a joint development agreement with inHealth to develop hypertension and cardiovascular programs for the products. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is headquartered in Sydney, Australia.",
    "website": "http://cardiex.com",
    "zipcode": "2000"
  },
  "CHEOF": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Cochlear Limited",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "COCHLEAR LTD",
    "state": "NSW",
    "summary": "Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.",
    "website": "http://www.cochlear.com",
    "zipcode": "2109"
  },
  "CHEOY": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Cochlear Limited",
    "market": "us_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "COCHLEAR LTD",
    "state": "NSW",
    "summary": "Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.",
    "website": "http://www.cochlear.com",
    "zipcode": "2109"
  },
  "CMP.AX": {
    "city": "Abbotsford",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Compumedics Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "COMPUMEDIC FPO",
    "state": "VIC",
    "summary": "Compumedics Limited researches, develops, manufactures, sells, and distributes medical devices in Australia, the Asia Pacific, the Americas, Europe, and the Middle East. It provides sleep diagnostics products, including Grael 4K PSG:EEG amplifiers; SomtÃ© PSG; Siesta 802, an ambulatory recording device; Grael PSG; and SomtÃ©, an investigative tool. The company also provides neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Xegis Forte EMG/EP; and Xegis G:NEO 2 Channel EMG/EP systems. In addition, it offers software products, such as Profusion Sleep software suite; Profusion EEG Software; ProFusion neXus 360, a Web-based patient data and lab management system that provides integrated hardware and software solutions for sleep and neurology clinics; Multi-Modal Neuroimaging Suite; Profusion neXus Laboratory Management System to optimize administrative and operational workflow needs of diagnostic and research laboratories; Profusion neXus Scheduler for planning for staff and time; and Digital Video, a plug-in software module to add synchronized digital video capabilities to sleep and EEG systems, as well as ECG Free, Profusion Plus, Siesta extended battery pack, and summit IP products. Further, the company provides magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; accessories; and a range of consumables and supplies for diagnostic and research solutions. The company was founded in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited is a subsidiary of D & DJ Burton Holdings Pty Ltd.",
    "website": "http://www.compumedics.com.au",
    "zipcode": "3067"
  },
  "COH.AX": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Cochlear Limited",
    "market": "au_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "COCHLEAR FPO",
    "state": "NSW",
    "summary": "Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.",
    "website": "http://www.cochlear.com",
    "zipcode": "2109"
  },
  "CSX.AX": {
    "city": "Artarmon",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "CleanSpace Holdings Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CLEANSPACE FPO",
    "state": "NSW",
    "summary": "CleanSpace Holdings Limited engages in the design and manufacture of respiratory protection equipment for healthcare and industrial employers worldwide. It offers CleanSpace HALO, a personal respiratory protection for healthcare; CleanSpace ULTRA, a respirator for eye protection and water tolerance; CleanSpace2, a respirator for various working environments; and CleanSpace EX, an air purifying respirator. The company also provides accessories comprising respirators, masks, filters, cleaning and storage products, biohood system parts, and spares. It serves mining, infrastructure, energy, transport, metal, chemical, healthcare, and defense and government organizations. CleanSpace Holdings Limited was founded in 2009 and is based in Artarmon, Australia.",
    "website": "http://cleanspacetechnology.com",
    "zipcode": "2064"
  },
  "CYC.AX": {
    "city": "Kingsgrove",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Cyclopharm Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "CYCLOPHARM FPO",
    "state": "NSW",
    "summary": "Cyclopharm Limited engages in the research and development, manufacture, and sale of medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. It offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The company also provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. It serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.",
    "website": "http://www.cyclopharm.com.au",
    "zipcode": "2208"
  },
  "EMV.AX": {
    "city": "Macquarie Park",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "EMvision Medical Devices Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "EMVISION FPO",
    "state": "NSW",
    "summary": "EMvision Medical Devices Limited engages in the research, development, and commercialization of imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, and other medical imaging needs. The company has a strategic collaboration with Keysight Technologies Malaysia Sdn Bhd to develop a personalized vector network analysis solution for medical imaging in the healthcare sector. EMvision Medical Devices Limited was founded in 2017 and is based in Macquarie Park, Australia.",
    "website": "http://www.emvision.com.au",
    "zipcode": "2113"
  },
  "EYE.AX": {
    "city": "Kent Town",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Nova Eye Medical Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "NOVA EYE FPO",
    "state": "SA",
    "summary": "Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.",
    "website": "http://www.nova-eye.com",
    "zipcode": "5067"
  },
  "FDMDF": {
    "city": "Melbourne",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "4DMedical Limited",
    "market": "us_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "4D MEDICAL LTD",
    "state": "VIC",
    "summary": "4DMedical Limited operates as a software technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging platform that utilizes proven and patented mathematic models and algorithms to convert X-ray scans into quantitative data to enhance the capacity of physicians to manage patients with respiratory diseases and diseases of the lung. The company is also developing VQ (Perfusion), a diagnostic to scan and measure ventilation and perfusion; and Contrast Free Pulmonary Angiography (CFPA) products, as well as small animal ventilators and preclinical scanners. 4Dmedical Limited partners with University of Miami Health System to establish the functional lung imaging research program. The company was founded in 2012 and is based in Melbourne, Australia.",
    "website": "http://www.4dmedical.com",
    "zipcode": "3004"
  },
  "HMD.AX": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "HeraMED Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "HERAMED FPO",
    "state": "NSW",
    "summary": "HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor principally for use by an expectant mother to monitor their fetus' heartbeat. It is also involved in developing EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is based in Sydney, Australia.",
    "website": "http://www.hera-med.com",
    "zipcode": "2000"
  },
  "IPD.AX": {
    "city": "Pinkenba",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "ImpediMed Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "IMPEDIMED FPO",
    "state": "QLD",
    "summary": "ImpediMed Limited, a medical software technology company, together with its subsidiaries, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive bioimpedance spectroscopy device for the detection of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.",
    "website": "http://www.impedimed.com",
    "zipcode": "4008"
  },
  "IPDQF": {
    "city": "Pinkenba",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "ImpediMed Limited",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "IMPEDIMED LIMITED",
    "state": "QLD",
    "summary": "ImpediMed Limited, a medical software technology company, together with its subsidiaries, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive bioimpedance spectroscopy device for the detection of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.",
    "website": "http://www.impedimed.com",
    "zipcode": "4008"
  },
  "KMLXF": {
    "city": "Melbourne",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Respiri Limited",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "RESPIRI LTD",
    "state": "VIC",
    "summary": "Respiri Limited, an e-health SaaS company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; and Wholter, a device for home ambulatory recording of nocturnal wheeze and cough. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.",
    "website": "http://www.respiri.co",
    "zipcode": "3004"
  },
  "LBT.AX": {
    "city": "Adelaide",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "LBT Innovations Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LABTECH FPO",
    "state": "SA",
    "summary": "LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia and Switzerland. It offers MicroStreak, an automated culture-plate streaking and inoculation system; Automated Plate Assessment System, an intelligent imaging and machine learning software; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. The company was founded in 2004 and is headquartered in Adelaide, Australia.",
    "website": "http://www.lbtinnovations.com",
    "zipcode": "5000"
  },
  "LSM.F": {
    "city": "Adelaide",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "LBT Innovations Limited",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "LBT INNOVATIONS LTD.",
    "state": "SA",
    "summary": "LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia and Switzerland. It offers MicroStreak, an automated culture-plate streaking and inoculation system; Automated Plate Assessment System, an intelligent imaging and machine learning software; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. The company was founded in 2004 and is based in Adelaide, Australia.",
    "website": "http://www.lbtinnovations.com",
    "zipcode": "5000"
  },
  "MX1.AX": {
    "city": "Tonsley",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Micro-X Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "MICRO-X FPO",
    "state": "SA",
    "summary": "Micro-X Limited designs, develops, and manufactures ultra-lightweight carbon nano tube based X-ray products for the healthcare and improvised explosive device imaging security markets in Australia. The company offers Carestream DRX Revolution Nano, an ultra-lightweight digital mobile X-ray system for bedside imaging for use in hospital wards and intensive care units; and Rover, a digital mobile X-Ray unit for deployed military hospitals. It is also developing Mobile Backscatter Imager for stand-off imaging of improvised explosive devices. The company was founded in 2011 and is based in Tonsley, Australia.",
    "website": "http://www.micro-x.com",
    "zipcode": "5042"
  },
  "N6A.F": {
    "city": "North Sydney",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "OncoSil Medical Limited",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ONCOSIL MEDICAL LTD",
    "state": "NSW",
    "summary": "OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. Its lead product is OncoSil, a brachytherapy device that implants a pre-determined dose of beta radiation directly into cancerous tissue for the treatment of cancer. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in June 2013. OncoSil Medical Limited is headquartered in North Sydney, Australia.",
    "website": "http://www.oncosil.com.au",
    "zipcode": "2060"
  },
  "NTI.AX": {
    "city": "Nedlands",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Neurotech International Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "NEUROTECH FPO",
    "state": "WA",
    "summary": "Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. Its product includes Mente Autism, a portable electroencephalographic medical device that uses neuro feedback to relax the minds of children with autism spectrum disorder. The company focuses on developing neuro-stimulation and neuro-diagnostic solutions that enable medical practitioners to monitor and play an active role in home-based therapies. It also engages in executing of medical research projects; and developing of technological devices and other solutions for the screening and treatment of neurological disorders. The company was incorporated in 2016 and is based in Nedlands, Australia.",
    "website": "http://www.neurotechinternational.com",
    "zipcode": "6009"
  },
  "OC5.F": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Cochlear Limited",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "COCHLEAR LTD",
    "state": "NSW",
    "summary": "Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.",
    "website": "http://www.cochlear.com",
    "zipcode": "2109"
  },
  "OC50.F": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Cochlear Limited",
    "market": "dr_market",
    "market_cap": "Large Cap",
    "sector": "Healthcare",
    "short_name": "COCHLEAR LTD ADR 1/2/O.N.",
    "state": "NSW",
    "summary": "Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.",
    "website": "http://www.cochlear.com",
    "zipcode": "2109"
  },
  "OSL.AX": {
    "city": "North Sydney",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "OncoSil Medical Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "ONCOSIL FPO",
    "state": "NSW",
    "summary": "OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. Its lead product is OncoSil, a brachytherapy device that implants a pre-determined dose of beta radiation directly into cancerous tissue for the treatment of cancer. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in June 2013. OncoSil Medical Limited is headquartered in North Sydney, Australia.",
    "website": "http://www.oncosil.com.au",
    "zipcode": "2060"
  },
  "OVN.AX": {
    "city": "Indooroopilly",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Oventus Medical Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "OVENTUS FPO",
    "state": "QLD",
    "summary": "Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a customized 3D-printed nylon oral appliance for OSA patients; and ExVent, an alternative for CPAP-intolerant individuals. It also develops O2Vent. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.",
    "website": "http://o2vent.com",
    "zipcode": "4068"
  },
  "QD4.F": {
    "city": "Rosebery",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "Quantum Health Group Limited",
    "market": "dr_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "QUANTUM HEALTH GROUP LTD.",
    "state": "NSW",
    "summary": "Quantum Health Group Limited distributes medical imaging and patient treatment equipment and services in Australia, Thailand, South Korea, Vietnam, New Zealand, the Philippines, and China. It operates in two segments, Medical and Environmental Services. The company distributes medical products in the field of radiology, oncology, aesthetics, and environmental health. It also manufactures energy saving heat pump technology used for heating and cooling systems internationally. The company was formerly known as Quantum Energy Limited. Quantum Health Group Limited was founded in 1975 and is headquartered in Rosebery, Australia.",
    "website": "http://www.qhealthcare.com.au",
    "zipcode": "2018"
  },
  "QTM.AX": {
    "city": "Rosebery",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Quantum Health Group Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "QUANTHEGRP FPO",
    "state": "NSW",
    "summary": "Quantum Health Group Limited distributes medical imaging and patient treatment equipment and services in Australia, Thailand, South Korea, Vietnam, New Zealand, the Philippines, and China. It operates in two segments, Medical and Environmental Services. The company distributes medical products in the field of radiology, oncology, aesthetics, and environmental health. It also manufactures energy saving heat pump technology used for heating and cooling systems internationally. The company was formerly known as Quantum Energy Limited. Quantum Health Group Limited was founded in 1975 and is headquartered in Rosebery, Australia.",
    "website": "http://www.qhealthcare.com.au",
    "zipcode": "2018"
  },
  "RHNMF": {
    "city": "Richmond",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "Rhinomed Limited",
    "market": "us_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "RHINOMED LIMITED",
    "state": "VIC",
    "summary": "Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It identifies, acquires, and commercializes nasal stent delivery technologies. The company's product portfolio includes Turbine for enhanced breathing in sports; Mute, an anti-snoring device; and Pronto for nasal congestion and sleep disturbance issues. It also engages in developing applications for the delivery of medical cannabis and conditions, including anxiety, pain, allergies, nausea, anxiety, and coughs and colds; and nasal swab to test the presence of upper respiratory tract diseases, including influenza, and coronavirus strains. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Richmond, Australia.",
    "website": "http://www.rhinomed.global",
    "zipcode": "3121"
  },
  "RHT.AX": {
    "city": "Burswood",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Resonance Health Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "RESONANCE FPO",
    "state": "WA",
    "summary": "Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services worldwide. Its flagship products include FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration; and FerriSmart, an automated software medical device to manage patients with iron overload disorders, such as thalassemia, sickle cell disease, hereditary haemochromatosis, anaemias, and cancers. The company also offers Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a magnetic resonance imaging (MRI) based tool for the measurement of volumetric liver fat fraction; HepaFat-AI, an artificial intelligence software tool, which is used for the automated assessment of liver fat from MRI data; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. It also provides imaging core laboratory and support services for clinical trials. The company serves clinicians for the diagnosis and management of human diseases; researchers; and pharmaceutical companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.",
    "website": "http://www.resonancehealth.com",
    "zipcode": "6100"
  },
  "RJV.F": {
    "city": "Crows Nest",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Medical Devices",
    "long_name": "SomnoMed Limited",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SOMNOMED LTD.",
    "state": "NSW",
    "summary": "SomnoMed Limited, together with its subsidiaries, produces and sells devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific Region. Its products include SomnoDent, an oral appliance for obstructive sleep apnea; and SomnoBrux, a mouthguard for the treatment of teeth grinding damage, as well as SomTabs for cleaning its devices. The company was founded in 2004 and is based in Crows Nest, Australia.",
    "website": "http://somnomed.com/au/",
    "zipcode": "2065"
  },
  "RNO.AX": {
    "city": "Richmond",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Rhinomed Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "RHINOMED FPO",
    "state": "VIC",
    "summary": "Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It identifies, acquires, and commercializes nasal stent delivery technologies. The company's product portfolio includes Turbine for enhanced breathing in sports; Mute, an anti-snoring device; and Pronto for nasal congestion and sleep disturbance issues. It also engages in developing applications for the delivery of medical cannabis and conditions, including anxiety, pain, allergies, nausea, anxiety, and coughs and colds; and nasal swab to test the presence of upper respiratory tract diseases, including influenza, and coronavirus strains. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Richmond, Australia.",
    "website": "http://www.rhinomed.global",
    "zipcode": "3121"
  },
  "RSH.AX": {
    "city": "Melbourne",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Respiri Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "RESPIRI FPO",
    "state": "VIC",
    "summary": "Respiri Limited, an e-health SaaS company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; and Wholter, a device for home ambulatory recording of nocturnal wheeze and cough. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.",
    "website": "http://www.respiri.co",
    "zipcode": "3004"
  },
  "RSN.SG": {
    "city": "Burswood",
    "country": "Australia",
    "currency": "EUR",
    "exchange": "STU",
    "industry": "Medical Devices",
    "long_name": "Resonance Health Limited",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "Resonance Health Ltd. Registere",
    "state": "WA",
    "summary": "Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services worldwide. Its flagship products include FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration; and FerriSmart, an automated software medical device to manage patients with iron overload disorders, such as thalassemia, sickle cell disease, hereditary haemochromatosis, anaemias, and cancers. The company also offers Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a magnetic resonance imaging (MRI) based tool for the measurement of volumetric liver fat fraction; HepaFat-AI, an artificial intelligence software tool, which is used for the automated assessment of liver fat from MRI data; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. It also provides imaging core laboratory and support services for clinical trials. The company serves clinicians for the diagnosis and management of human diseases; researchers; and pharmaceutical companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.",
    "website": "http://www.resonancehealth.com",
    "zipcode": "6100"
  },
  "SOM.AX": {
    "city": "Crows Nest",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "SomnoMed Limited",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SOMNOMED FPO",
    "state": "NSW",
    "summary": "SomnoMed Limited, together with its subsidiaries, produces and sells devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific Region. Its products include SomnoDent, an oral appliance for obstructive sleep apnea; and SomnoBrux, a mouthguard for the treatment of teeth grinding damage, as well as SomTabs for cleaning its devices. The company was founded in 2004 and is based in Crows Nest, Australia.",
    "website": "http://somnomed.com/au/",
    "zipcode": "2065"
  },
  "SOMNF": {
    "city": "Crows Nest",
    "country": "Australia",
    "currency": "USD",
    "exchange": "PNK",
    "industry": "Medical Devices",
    "long_name": "SomnoMed Limited",
    "market": "us_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "SOMNOMED LIMITED",
    "state": "NSW",
    "summary": "SomnoMed Limited, together with its subsidiaries, produces and sells devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific Region. Its products include SomnoDent, an oral appliance for obstructive sleep apnea; and SomnoBrux, a mouthguard for the treatment of teeth grinding damage, as well as SomTabs for cleaning its devices. The company was founded in 2004 and is based in Crows Nest, Australia.",
    "website": "http://somnomed.com/au/",
    "zipcode": "2065"
  },
  "UBI.AX": {
    "city": "Rowville",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Universal Biosensors, Inc.",
    "market": "au_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "UNI BIOSEN CDI 1:1",
    "state": "VIC",
    "summary": "Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It offers SENTIA Wine Analyzer to test Free Sulphur Dioxide; prothrombin time international normalized ratio coagulation test strips; Sentia Free Sulphite test strips; and coagulation testing and calibration services, as well as distributes Siemens' Xprecia Stride Coagulation Analyzer. The company has a license agreement with LifeScan Global Corporation to develop a biosensor strip and a meter to be used for the detection and monitoring of diabetes in animals. Universal Biosensors, Inc. was incorporated in 2001 and is headquartered in Rowville, Australia.",
    "website": "http://www.universalbiosensors.com",
    "zipcode": "3178"
  },
  "UCM.AX": {
    "city": "Sydney",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Medical Devices",
    "long_name": "Uscom Limited",
    "market": "au_market",
    "market_cap": "Nano Cap",
    "sector": "Healthcare",
    "short_name": "USCOM FPO",
    "state": "NSW",
    "summary": "Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company provides Ventitest, a ventilator testing device; Ventitest sensor to test lung function; and The SpiroSonic AIR, a digital home care spirometer which feeds digital lung function signals through a phone app. It serves hospitals and other medical care locations through a network of distribution partners. The company was incorporated in 1999 and is headquartered in Sydney, Australia.",
    "website": "http://www.uscom.com.au",
    "zipcode": "2000"
  }
}
